Skip to main content

Davis Polk & Wardwell and Jia Yuan Law Offices have advised Chinese clinical trial and research firm Hangzhou Tigermed Consulting on its $1.38 billion Hong Kong IPO, with Freshfields Bruckhaus Deringer and Zhong Lun Law Firm representing the sponsors.

Tigermed, which is already listed in Shenzhen, is the largest clinical research trial provider in mainland China. According to Reuters, Tigermed will sell 107.06 million shares in this IPO, which could make the deal the largest healthcare transaction in Asia this year, topping WuXi Biologics’ $984 million share placement in May.

The Jia Yuan Law Offices team advising on the deal was led by partners Wang Yuan and Fu Yangyuan.

Meanwhile, partners Zhang Jinquan, Zhu Ying, Zhong Yang and Li Xiang led the Zhong Lun Law Firm team.

 

To contact the editorial team, please email ALBEditor@thomsonreuters.com.

Related Articles

Deals

9 firms advise on milestone $8.2 bln cross-border insurance deal

by Sarah Wong |

Global law firms Debevoise & Plimpton, Kirkland & Ellis and Herbert Smith Freehills are acting for Bermuda-based insurer Resolution Life on its $8.2 billion sale to Japan’s Nippon Life Insurance, the largest overseas acquisition by a Japanese insurer to date.

Deals

Top international firms act on landmark $7.1 bln ESR take-private deal

by Nimitt Dixit |

Global law firms Freshfields, Latham & Watkins, Kirkland & Ellis, Paul, Weiss, Rifkind, Wharton & Garrison and Cleary Gottlieb Steen & Hamilton have steered an offer to take the Hong Kong-listed ESR Group private in a deal valued at $7.1 billion.

Deals

Fangda, KWM act on HKAA’s $592 mln acquisition of Zhuhai Airport stake

by Hu Yangxiaoxiao 胡阳潇潇 |

Fangda Partners has advised the Hong Kong Airport Authority (HKAA) on its agreement to purchase a 35 percent stake in Zhuhai Airport for approximately $592 million, with King & Wood Mallesons representing the seller, Zhuhai Transportation.